In a report released today, James Edwardes Jones from RBC Capital maintained a Buy rating on Reckitt (RKT – Research Report), with a price ...

In a report released today, Dara Mohsenian from Morgan Stanley maintained a Hold rating on Kimberly Clark (KMB – Research Report), with a price ...

RBC Capital Markets adjusted their outlook on Morgan Stanley (NYSE:MS) shares, raising the price target from $122.00 to ...

Obesity drug developer Aardvark Therapeutics (AARD) has filed for a $100M initial public offering. Aardvark (AARD) didn't ...

Bank stocks have been on a post-election upswing, with the KBW Nasdaq Bank Index ( ^BKX) up 14% since Trump won the ...

Issuance for next week falls to an estimated $5.151 billion, with $3.959 billion of negotiated deals and $1.193 billion of ...

Citi (C), JPMorgan Chase (JPM), Goldman Sachs (GS), and Wells Fargo (WFC) report on Wednesday, while Bank of America (BAC) and Morgan Stanley (MS) release results on Thursday. RBC Capital markets ...

RBC Capital Markets analyst Maurice Choy identifies relative “safer havens” in the yield-heavy energy infrastructure sector, ...

Wells Fargo has recently reduced T-Mobile Us Inc (TMUS) stock to Equal Weight rating, as announced on January 6, 2025, according to Finviz. Earlier, on January 6, 2025, RBC Capital Mkts had reduced ...

Dyne Therapeutics Inc (DYN) stock saw a modest uptick, ending the day at $14.55 which represents a slight increase of $0.42 or 2.97% from the prior close of $14.13. The stock opened at $14.3 and ...

On Thursday, RBC Capital Markets adjusted its outlook on shares of JPMorgan Chase & Co. (NYSE: NYSE:JPM) shares by increasing the price target to $260 from the previous $248, while retaining an ...